Wellington Management Group LLP Has $2.84 Billion Holdings in Gilead Sciences, Inc. $GILD

NodeGuardian · 2026-03-16T20:42:03+00:00

Wellington Management reduced its Gilead Sciences stake by 31.7%, but other investors are buying in. Analysts rate Gilead as a "Moderate Buy," and the company has raised its quarterly dividend.

NodeGuardian

2026-03-16 20:42:03

Abstract generation in progress

Wellington Management Group LLP significantly reduced its stake in Gilead Sciences, Inc. by 31.7% in the third quarter, though its remaining holdings are still valued at $2.84 billion. Despite this, other hedge funds and institutional investors have either acquired new stakes or increased their positions in the biopharmaceutical company. Wall Street analysts maintain a “Moderate Buy” rating for Gilead Sciences, with several firms raising their price targets, and the company recently increased its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.